Search Within

Alan Loh Ho

Formats
  1. Journal Article (111)
  2. Meeting Abstract (104)
  3. Review (7)
  4. Editorial (4)
  5. Guidelines (4)
  6. Research Letter (4)
  7. Book Section (2)
  8. Miscellaneous (1)
Groups
  1. Department of Medicine (237)
  2. Head and Neck Service (237)
  3. Solid Tumor Oncology Division (237)
  4. Department of Pathology and Laboratory Medicine (93)
  5. Surgery (78)
  6. GSK Faculty (69)

More Groups

People
  1. David Pfister (89)
  2. Eric Sherman (84)
  3. Lara Dunn (53)
  4. Nora Katabi (48)
  5. Nancy Lee (42)
  6. Sofia Haque (40)

More People

Years
  1. 2025 (5)
  2. 2024 (25)
  3. 2023 (26)
  4. 2022 (23)
  5. 2021 (18)
  6. 2020 (21)

More Years

Publications
  1. Journal of Clinical Oncology (73)
  2. Annals of Oncology (20)
  3. International Journal of Radiation Oncology, Biology, Physics (14)
  4. Cancer Research (10)
  5. Clinical Cancer Research (8)
  6. Journal of the National Comprehensive Cancer Network (8)

More Publications

Publishers
  1. American Society of Clinical Oncology (75)
  2. Elsevier Inc. (27)
  3. Oxford University Press (24)
  4. American Association for Cancer Research (23)
  5. Springer (11)
  6. Wiley Blackwell (11)

More Publishers

Results (237)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II trial of rivoceranib, an oral vascular endothelial growth factor receptor 2 inhibitor, for recurrent or metastatic adenoid cystic carcinoma
    Journal Article

    Hanna, G. J.; Ahn, M. J.; Muzaffar, J.; Keam, B.; Bowles, D. W.; Wong, D. J.; Ho, A. L.; Kim, S. B.; Worden, F.; Yun, T.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma
    Journal Article

    Valero, C.; Golkaram, M.; Vos, J. L.; Xu, B.; Fitzgerald, C.; Lee, M.; Kaplan, S.; Han, C. Y.; Pei, X.; Sarkar, R.; more...
    Journal of Clinical Investigation (2023)

    Fulltext@MSK | Save
  • A phase 2 study of neoadjuvant lenvatinib in locally advanced invasive thyroid cancer
    Meeting Abstract

    Abdelhamid Ahmed, A. H.; Russell, M. D.; Kyriazidis, N.; Silver Karcioglu, A.; Sherman, E. J.; Ho, A. L.; Fagin, J. A.; Wong, R. J.; Busaidy, N. L.; Zafereo, M. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase 2 open-label study of conditionally active biologic ozuriftamab vedotin (BA3021) in failed PD-1/L1 treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck
    Meeting Abstract

    Ho, A. L.; Adkins, D.; Lorch, J. H.; Thomas, J. S.; Grewal, J. S.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Updated results from a phase 2 study of the oral vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor rivoceranib for recurrent or metastatic (R/M) adenoid cystic carcinoma (ACC)
    Meeting Abstract

    Kang, H.; Ahn, M. J.; Keam, B.; Bowles, D. W.; Wong, D. J. L.; Ho, A. L.; Kim, S. B.; Worden, F. P.; Yun, T.; Jang, S.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II study of lenvatinib plus pembrolizumab in patients with progressive, recurrent/metastatic adenoid cystic carcinoma
    Meeting Abstract

    Mohamadpour, M.; Sherman, E. J.; Kriplani, A.; Fetten, J. V.; Dunn, L.; Michel, L. S.; Hung, K. W.; Baxi, S. S.; McDonald, E.; Conybeare, R.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase 1 study of concurrent cabozantinib and cetuximab in recurrent or metastatic head and neck squamous cell cancer
    Meeting Abstract

    Desilets, A.; Pfister, D. G.; Wong, W.; Sherman, E. J.; Fetten, J. V.; Hung, K. W.; Dunn, L.; Ho, A. L.; Michel, L. S.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Neoadjuvant cemiplimab with platinum-doublet chemotherapy and cetuximab to de-escalate surgery and omit adjuvant radiation in locoregionally advanced head & neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    Wong, W.; Cracchiolo, J. R.; Riaz, N.; Ganly, I.; Sherman, E. J.; Ho, A. L.; Morris, L.; Ghossein, R. A.; Haque, S.; Hung, K. W.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Final analysis of multi-histology basket trial expansion of ado-trastuzumab emtansine in patients with HER2 amplified cancers
    Meeting Abstract

    Liu, D.; Makker, V.; Buonocore, D. J.; Shen, R.; Yaeger, R.; Ginsberg, M. S.; Yeh, R.; Johnson, A.; Offin, M.; Solit, D. B.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): A regression-based prediction interval tool for the management of well-differentiated thyroid cancer patients
    Journal Article

    Mauguen, A.; Grewal, R. K.; Augensen, F.; Abusamra, M.; Mahajan, S.; Jayaprakasam, V. S.; Osborne, J.; Haque, S.; Wong, B. Z. Y.; Ghossein, R. A.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save